Nutex Health Inc NUTX.OQ reported a quarterly adjusted loss of $1.72 per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of $-1.50. The mean expectation of two analysts for the quarter was for a loss of 24 cents per share. Wall Street expected results to range from -76 cents to 28 cents per share.
Revenue rose 25.6% to $78.79 million from a year ago; analysts expected $73.22 million.
Nutex Health Inc's reported EPS for the quarter was a loss of $1.72.
The company reported a quarterly loss of $8.79 million.
Nutex Health Inc shares had risen by 33.1% this quarter and gained 7.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had risen by about 44.2% in the last three months.
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 2 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."
The average consensus recommendation for the healthcare facilities & services peer group is also "buy"
Wall Street's median 12-month price target for Nutex Health Inc is 45.00
This summary was machine generated from LSEG data November 8 at 09:02 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
Sep. 30 2024 | -0.24 | -1.72 | Missed |
Jun. 30 2024 | -0.29 | -0.07 | Beat |
Mar. 31 2024 | 0.00 | -0.60 | Missed |
Dec. 31 2023 | 0.00 | 0.00 | Met |
Comments